TREATMENT OF OSTEOARTHRITIS WITH A HERBOMINERAL FORMULATION - A DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSS-OVER STUDY

被引:127
|
作者
KULKARNI, RR
PATKI, PS
JOG, VP
GANDAGE, SG
PATWARDHAN, B
机构
[1] UNIV POONA,INTERDISCIPLINARY SCH AYURVED MED,POONA 411007,MAHARASHTRA,INDIA
[2] UNIV POONA,BRYAMJEE JEEJEEBHOY MED COLL,POONA 411007,MAHARASHTRA,INDIA
[3] UNIV POONA,SASSOON GEN HOSP,POONA 411007,MAHARASHTRA,INDIA
关键词
ARTHRITIS; OSTEOARTHRITIS; CLINICAL TRIAL; HERBOMINERAL; AYURVEDIC;
D O I
10.1016/0378-8741(91)90167-C
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
The clinical efficacy of a herbomineral formulation containing roots of Withania somnifera, the stem of Boswellia serrata, rhizomes of Curcuma longa and a zinc complex (Articulin-F), was evaluated in a randomized, double-blind, placebo controlled, cross-over study in patients with osteoarthritis. After a one-month single blind run-in period, 42 patients with osteoarthritis were randomly allocated to receive either a drug treatment or a matching placebo for a period of three months. After a 15-day wash-out period the patients were transferred to the other treatment for a further period of three months. Clinical efficacy was evaluated every fortnight on the basis of severity of pain, morning stiffness, Ritchie articular index, joint score, disability score and grip strength. Other parameters like erythrocyte sedimentation rate and radiological examination were carried out on a monthly basis. Treatment with the herbomineral formulation produced a significant drop in severity of pain (P < 0.001) and disability score (P < 0.05). Radiological assessment, however, did not show any significant changes in both the groups. Side effects observed with this formulation did not necessitate withdrawal of treatment.
引用
收藏
页码:91 / 95
页数:5
相关论文
共 50 条
  • [1] DOUBLE-BLIND CROSS-OVER PLACEBO-CONTROLLED STUDY OF OMEPRAZOLE IN THE TREATMENT OF THE SENSITIVE ESOPHAGUS
    WATSON, RGP
    THAM, TCK
    JOHNSTON, BT
    GASTROENTEROLOGY, 1995, 108 (04) : A255 - A255
  • [2] Baclofen treatment for rumination syndrome: a double-blind, placebo-controlled, cross-over study
    Pauwels, A.
    Broers, C.
    Van Houtte, B.
    Rommel, N.
    Vanuytsel, T.
    Tack, J.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2016, 28 : 19 - 19
  • [3] Naltrexone augmentation in OCD: A double-blind placebo-controlled cross-over study
    Amiaz, Revital
    Fostick, Leah
    Gershon, Ari
    Zohar, Joseph
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 (06) : 455 - 461
  • [4] Levosulpiride in somatoform disorders: A double-blind, placebo-controlled cross-over study
    Altamura, AC
    Di Rosa, A
    Ermentini, A
    Guaraldi, GP
    Invernizzi, G
    Rudas, N
    Tacchini, G
    Pioli, R
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2003, 7 (03) : 155 - 159
  • [5] DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSS-OVER STUDY OF FLAVOXATE IN THE TREATMENT OF IDIOPATHIC DETRUSOR INSTABILITY
    CHAPPLE, CR
    PARKHOUSE, H
    GARDENER, C
    MILROY, EJG
    BRITISH JOURNAL OF UROLOGY, 1990, 66 (05): : 491 - 494
  • [6] CYCLANDELATE IN DIABETIC NEUROPATHY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, CROSS-OVER STUDY
    HEIMANS, JJ
    DRUKARCH, B
    MATTHAEI, I
    IJFF, GA
    BERTELSMANN, FW
    STRIJERS, RLM
    NAUTA, J
    ACTA NEUROLOGICA SCANDINAVICA, 1991, 84 (06): : 483 - 486
  • [7] Dapsone in Behcet's disease: A double-blind, placebo-controlled, cross-over study
    Sharquie, KE
    Najim, RA
    Abu-Raghif, AR
    JOURNAL OF DERMATOLOGY, 2002, 29 (05): : 267 - 279
  • [8] Nutcracker oesophagus: a double-blind, placebo-controlled, cross-over study of the effects of lansoprazole
    Borjesson, M
    Rolny, P
    Mannheimer, C
    Pilhall, M
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (11-12) : 1129 - 1135
  • [9] Differential effects of escitalopram on attention: a placebo-controlled, double-blind cross-over study
    Drueke, Barbara
    Baetz, Julia
    Boecker, Maren
    Moeller, Olaf
    Hiemke, Christoph
    Gruender, Gerd
    Gauggel, Siegfried
    PSYCHOPHARMACOLOGY, 2009, 207 (02) : 213 - 223
  • [10] Levodopa for chronic neck pain: A cross-over double-blind, placebo-controlled study
    Marziniak, M
    Guralnik, V
    Dillmann, U
    Becker, G
    MOVEMENT DISORDERS, 2004, 19 : S393 - S394